Skip to main content

Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response Lessons from COVID-19 (2022) / Chapter Skim
Currently Skimming:

Appendix A: Committee Biographies
Pages 131-136

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 131...
... She is a past member of the National Academies' Report Review Committee and has served on numerous government advisory groups including for the U.S. Centers for Disease Control and Prevention and the National Institutes of Health.
Read the entire page →
From page 132...
... She is an internationally recognized vaccine scientist and global health advocate with more than two decades of contributions in science, biotechnology, and vaccine development tackling neglected and emerging infectious diseases. As a global thought leader she has received national and international highly regarded awards, has more than 180 scientific papers, and participated in more than 250 conferences worldwide.
Read the entire page →
From page 133...
... She has serves as an advisor to the World Health Organization SAGE Immunization Working Group on Influenza and the European Medicines Agency. She is the deputy chair of influenza and other respiratory viruses and the senior editor for the journal Influenza and Other Respiratory Viruses and the associate editor of the journals Human Vaccines and Immunotherapeutics and Vaccines.
Read the entire page →
From page 134...
... He has focused on the development of broadly neutralizing anti-hemagglutinin stalk antibodies and the design of a universal influenza virus vaccine. The Krammer laboratory, which is also part of the National Institutes of Health–funded Centers for Excellence in Influenza Research and Surveillance, focuses on understanding broadly reactive immune responses against the surface glycoproteins of RNA viruses such as influenza with the goal to develop better vaccines and novel therapeutics.
Read the entire page →
From page 135...
... Sharfstein, M.D., is the vice dean for public health practice and community engagement and a professor of the practice in health policy and management at the Johns Hopkins Bloomberg School of Public Health. He is also the director of the Bloomberg American Health Initiative.
Read the entire page →

Key Terms

  • vaccine development
  • influenza virus
  • collaborating centre
  • pediatric infectious
  • diseases society

  • vaccine responses
  • candidate vaccine
  • respiratory viruses
  • research platform
  • health practice

  • influenza vaccine
  • internationally recognized
  • respiratory syndrome
  • emerging respiratory
  • school failure

  • understanding broadly
  • community engagement
  • mammalian cells
  • mune responses
  • strain coverage

  • biotechnology heritage
  • sage immunization
  • novel influenza
  • postdoctoral training
  • government advisory

  • global thought
  • prior influenza
  • single tablet
  • undertook pioneering
  • wellesley college


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.